$32.44
-0.41[-1.25%]
At close: Apr 19
$32.44
0[0.00%]
After Hours: 4:00PM EDT
Tarsus Pharmaceuticals
(NASDAQ:TARS)Tarsus Pharmaceuticals Stock (NASDAQ:TARS), Earnings Estimates, EPS, and Revenue
Tarsus Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-1.250
Quarterly Revenue Estimate
$17.1M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$17.4M
Analyze the earnings history of Tarsus Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/07/2024 | PM | TARS | Q1 | -$0.88 | -$1.25 | — | — | $2.50M | $17.15M | — | — | Get Alert |
| 02/27/2024 | AM | TARS | Q4 | -$0.49 | -$1.36 | -$1.31 | 3.68% | $10.00M | $5.66M | $13.08M | 131.02% | Get Alert |
| 11/09/2023 | PM | TARS | Q3 | -$0.84 | -$1.36 | -$1.28 | 5.88% | $0.00 | $400.00K | $1.87M | 367.75% | Get Alert |
| 08/10/2023 | PM | TARS | Q2 | -$0.24 | -$1.08 | -$1.17 | -8.33% | $15.28M | — | $0.00 | — | Get Alert |
| 05/09/2023 | PM | TARS | Q1 | -$0.98 | -$0.94 | -$0.88 | 6.38% | $539.00K | $3.12M | $2.50M | -19.87% | Get Alert |
| 03/13/2023 | PM | TARS | Q4 | -$0.72 | -$0.69 | -$0.49 | 28.99% | $338.00K | $10.00M | $10.00M | 0.00% | Get Alert |
| 11/09/2022 | AM | TARS | Q3 | -$0.76 | -$0.97 | -$0.84 | 13.40% | $1.24M | — | $0.00 | — | Get Alert |
| 08/11/2022 | PM | TARS | Q2 | $0.29 | -$1.08 | -$0.24 | 77.78% | $22.02M | $13.00M | $15.28M | 17.52% | Get Alert |
| 05/10/2022 | PM | TARS | Q1 | $0.47 | -$0.92 | -$0.98 | -6.52% | $33.43M | — | $539.00K | — | Get Alert |
| 03/14/2022 | PM | TARS | Q4 | -$1.85 | -$0.73 | -$0.72 | 1.37% | $0.00 | $338.00K | $338.00K | 0.00% | Get Alert |
| 11/09/2021 | PM | TARS | Q3 | -$3.71 | -$0.43 | -$0.76 | -76.74% | $0.00 | $5.33M | $1.24M | -76.74% | Get Alert |
| 08/04/2021 | AM | TARS | Q2 | — | -$0.48 | $0.29 | 160.42% | — | $4.53M | $22.02M | 386.03% | Get Alert |
| 05/11/2021 | PM | TARS | Q1 | -$0.74 | -$0.64 | $0.47 | 173.44% | — | $33.43M | $33.43M | 0.01% | Get Alert |
| 03/31/2021 | PM | TARS | Q4 | — | -$0.66 | -$1.85 | -180.30% | — | — | $0.00 | — | Get Alert |
| 11/25/2020 | AM | TARS | Q3 | — | — | -$3.71 | — | — | — | $0.00 | — | Get Alert |
FAQ
When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?
Tarsus Pharmaceuticals (TARS) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 27, 2024 for Q4.
What were the latest earnings per share (EPS) for Tarsus Pharmaceuticals (NASDAQ:TARS)?
The Actual EPS was $-1.31, which beat the estimate of $-1.36.
What were Tarsus Pharmaceuticals’s (NASDAQ:TARS) revenues?
The Actual Revenue was $13.1M, which beat the estimate of $5.7M.
Browse earnings estimates, EPS, and revenue on all stocks.